A NUDEL-dependent mechanism of neurofilament assembly regulates the integrity of CNS neurons

Nature Cell Biology

Volumn 6, Issue 7, 2004, Pages 595-608

  Nguyen, Minh Dang ^a,b   Shu, Tianzhi ^a   Sanada, Kamon ^a   Larivière, Roxanne C ^b,c   Tseng, Huang Chun ^a   Park, Sang Ki ^a   Julien, Jean Pierre ^b,c   Tsai, Li Huei ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MONTREAL GENERAL HOSPITAL   (Canada)

^c LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOPLASM PROTEIN; NEUROFILAMENT PROTEIN; PROTEIN NUDEL; PROTEIN SUBUNIT; RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPERGILLUS NIDULANS; BRAIN CORTEX; CELL NUCLEUS; CELL TRANSPORT; CELLULAR DISTRIBUTION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; CORRELATION COEFFICIENT; HISTOPATHOLOGY; HOMEOSTASIS; HUMAN; HUMAN CELL; KNOCKOUT MOUSE; MAMMAL CELL; MOUSE; NERVE CELL; NERVE DEGENERATION; NEUROBLASTOMA CELL; NEUROFILAMENT; NONHUMAN; PERINATAL PERIOD; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN POLYMERIZATION; REGULATORY MECHANISM; RNA INTERFERENCE; SEQUENCE HOMOLOGY; TUMOR CELL LINE;

ANIMALS; ANIMALS, NEWBORN; CARRIER PROTEINS; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELLS, CULTURED; CENTRAL NERVOUS SYSTEM; DISEASE MODELS, ANIMAL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROFILAMENTS; MICROSCOPY, ELECTRON; NEURODEGENERATIVE DISEASES; NEUROFILAMENT PROTEINS; NEURONS; POLYMERS; PROTEIN TRANSPORT; RNA INTERFERENCE;

ANIMALIA; ASPERGILLUS; EMERICELLA NIDULANS; MAMMALIA;

EID: 3242706075     PISSN: 14657392     EISSN: None     Source Type: Journal    
DOI: 10.1038/ncb1139     Document Type: Article

References (48)

1. Morris, J. A., Kandpal, G., Ma, L. & Austin, C. P. DISC1 (disrupted in schizophrenia 1) is a centrosome-associated protein that interacts with MAP1A, MIPT3, ATF4/5 and NUDEL: regulation and loss of interaction with mutation. Hum. Mol. Genet. 12, 1591-608 (2003).
2. Niethammer, M. et al. NUDEL is a novel Cdk5 substrate that associates with LIS1 and cytoplasmic dynein. Neuron 28, 697-711 (2000).
3. Sasaki, S. et al. A LIS1/NUDEL/cytoplasmic dynein heavy chain complex in the developing and adult nervous system. Neuron 28, 681-696 (2000).
4. Smith, D. S. et al. Regulation of cytoplasmic dynein behaviour and microtubule organization by mammalian Lis1. Nature Cell Biol. 2, 767-775 (2000).
5. Toyo-oka, K. et al. 14-3-3E is important for neuronal migration by binding to NUDEL: a molecular explanation for Miller-Dieker syndrome. Nature Genet. 34, 274-285 (2003).
6. Fuchs, E. & Cleveland, D. W. A structural scaffolding of intermediate filaments in health and disease. Science 279, 514-519 (1998).
7. Julien, J. P. Neurofilament functions in health and disease. Curr. Opin. Neurobiol. 9, 554-560 (1999).
8. Julien, J. P. & Mushynski, W. E. Neurofilaments in health and disease. Prog. Nucleic Acid Res. Mol. Biol. 61, 1-23 (1998).
9. Lariviere, R. C. & Julien, J. P. Functions of intermediate filaments in neuronal development and disease. J. Neurobiol. 58, 131-48 (2004).
10. Lee, M. K. & Cleveland, D. W. Neuronal intermediate filaments. Annu. Rev. Neurosci. 19, 187-217 (1996).
11. Kost, S. A., Chacko, K. & Oblinger, M. M. Developmental patterns of intermediate filament gene expression in the normal hamster brain. Brain Res. 595, 270-280 (1992).
12. Schlaepfer, W. W. & Bruce, J. Simultaneous up-regulation of neurofilament proteins during the postnatal development of the rat nervous system. J. Neurosci. Res. 25, 39-49 (1990).
13. Zhu, Q., Couillard-Despres, S. & Julien, J. P. Delayed maturation of regenerating myelinated axons in mice lacking neurofilaments. Exp. Neurol. 148, 299-316 (1997).
14. Bennett, G. S. & DiLullo, C. Slow post-translational modification of a neurofilament protein. J. Cell Biol. 100, 1799-1804 (1985).
15. Black, M. M., Keyser, P. & Sobel, E. Interval between the synthesis and assembly of cytoskeletal proteins in cultured neurons. J. Neurosci. 6, 1004-1012 (1986).
16. Rao, M. V. et al. Myosin Va binding to neurofilaments is essential for correct myosin Va distribution and transport and neurofilament density. J. Cell Biol. 159, 279-290 (2002).
17. Roy, S. et al. Neurofilaments are transported rapidly but intermittently in axons: implications for slow axonal transport. J. Neurosci. 20, 6849-6861 (2000).
18. Shah, J. V., Flanagan, L, A., Janmey, P. A. & Leterrier, J. F. Bidirectional translocation of neurofilaments along microtubules mediated in part by dynein/dynactin. Mol. Biol. Cell 11, 3495-3508 (2000).
19. Wang, L., Ho, C. L., Sun, D., Liem, R. K. & Brown, A. Rapid movement of axonal neurofilaments interrupted by prolonged pauses. Nature Cell Biol. 2, 137-141 (2000).
20. Yabe, J. T., Pimenta, A. & Shea, T. B. Kinesin-mediated transport of neurofilament protein oligomers in growing axons. J. Cell Sci. 112, 3799-3814 (1999).
21. Helfand, B. T., Chang, L. & Goldman, R. D. The dynamic and motile properties of intermediate filaments. Annu. Rev. Cell Dev. Biol. 19, 445-467 (2003).
22. Helfand, B. T., Chang, L. & Goldman, R. D. Intermediate filaments are dynamic and motile elements of cellular architecture. J. Cell Sci. 117, 133-141 (2004).
23. Jung, C., Yabe, J., Wang, F. S. & Shea, T. B. Neurofilament subunits can undergo axonal transport without incorporation into Triton-insoluble structures. Cell. Motil. Cytoskeleton 40, 44-58 (1998).
24. Julien, J. P. & Mushynski, W. E. The distribution of phosphorylation sites among identified proteolytic fragments of mammalian neurofilaments. J. Biol. Chem. 258, 4019-4025 (1983).
25. Beaulieu, J. M., Jacomy, H. & Julien, J. P. Formation of intermediate filament protein aggregates with disparate effects in two transgenic mouse models lacking the neurofilament light subunit. J. Neurosci. 20, 5321-5328 (2000).
26. Beaulieu, J. M., Robertson, J. & Julien, J. P. Interactions between peripherin and neurofilaments in cultured cells: disruption of peripherin assembly by the NF-M and NF-H subunits. Biochem. Cell Biol. 77, 41-45 (1999).
27. Lee, M. K., Xu, Z., Wong, P. C. & Cleveland, D. W. Neurofilaments are obligate heteropolymers in vivo. J. Cell Biol. 122, 1337-1250 (1993).
28. Fujita, Y., Okamoto, K., Sakurai, A., Gonatas, N. K. & Hirano, A. Fragmentation of the Golgi apparatus of the anterior horn cells in patients with familial amyotrophic lateral sclerosis with SOD1 mutations and posterior column involvement. J. Neurol. Sci. 174, 137-140 (2000).
29. Helfand, B. T., Mendez, M. G., Pugh, J., Delsert, C. & Goldman, R. D. A role for intermediate filaments in determining and maintaining the shape of nerve cells. Mol. Biol. Cell 14, 5069-5081 (2003).
30. Xie, Z., Sanada, K., Samuels, B. A., Shih, H. & Tsai, L. H. Serine-732 phosphorylation of FAK by Cdk5 is important for microtubule organization, nuclear movement, and neuronal migration. Cell 114, 469482 (2003).
31. Julien, J. P. Amyotrophic lateral sclerosis: unfolding the toxicity of the misfolded. Cell 104, 581-591 (2001).
32. Nguyen, M. D,, Lariviere, R. C. & Julien, J. P. Deregulation of Cdk5 in a mouse model of ALS: toxicity alleviated by perikaryal neurofilament inclusions. Neuron 30, 135-147 (2001).
33. Couillard-Despres, S. et al. Protective effect of neurofilament-heavy-gene overexpression in motor neuron disease induced by mutant superoxide dismutase. Proc. Natl Acad. Sci. USA 95, 9626-9630 (1998).
34. Hirokawa, N., Glicksman, M. A. & Willard, M. B. Organization of mammalian neurofilament polypeptides within the neuronal cytoskeleton. J. Cell Biol. 98, 1523-1536 (1984).
35. Hisanaga, S. & Hirokawa, N. Structure of the peripheral domains of neurofilaments revealed by low angle rotary shadowing. J. Mol. Biol. 202, 297-305 (1988).
36. Yuan, A., Rao, M. V., Kumar, A., Julien, J. P. & Nixon, R. A. Neurofilament transport in vivo minimally requires hetero-oligomer formation. J. Neurosci. 23, 9452-9458 (2003).
37. Carpenter, S. Proximal axonal enlargement in motor neuron disease. Neurology 18, 841-851 (1968).
38. Rouleau, G. A. et al. SOD1 mutation is associated with accumulation of neurofilaments in amyotrophic lateral sclerosis. Ann. Neurol. 39, 128-131 (1996).
39. Schmidt, M. L. et al. Epitope map of neurofilament protein domains in cortical and peripheral nervous system Lewy bodies. Am. J. Pathol. 139, 53-65 (1991).
40. Bergeron, C. et al. Neurofilament-light and polyadenylated mRNA levels are decreased in amyotrophic lateral sclerosis motor neurons. J. Neuropathol. Exp. Neurol. 53, 221-230 (1994).
41. Hill, W. D., Arai, M., Cohen, J. A. & Trojanowski, J. Q. Neurofilament mRNA is reduced in Parkinson's disease substantia nigra pars compacta neurons. J. Comp. Neurol. 329, 328-336 (1993).
42. McLachlan, D. R., Lukiw, W. J., Wong, L., Bergeron, C. & Bech-Hansen, N. T. Selective messenger RNA reduction in Alzheimer's disease. Brain Res. 427, 255-261 (1988).
43. Menzies, F. M. et al. Selective loss of neurofilament expression in Cu/Zn superoxide dismutase (SOD1) linked amyotrophic lateral sclerosis. J. Neurochem. 82, 1118-1128 (2002).
44. Morrison, B. M., Shu, I. W., Wilcox, A. L., Gordon, J. W. & Morrison, J. H. Early and selective pathology of light-chain neurofilament in the spinal cord and sciatic nerve of G86R mutant superoxide dismutase transgenic mice. Exp. Neurol. 165, 207-220 (2000).
45. Kong, J. & Xu, Z. Overexpression of neurofilament subunit NF-L and NF-H extends survival of a mouse model for amyotrophic lateral sclerosis. Neurosci. Lett. 281, 72-74 (2000).
46. Sui, G., Soohoo, C., Affar el, B., Gay, F., Shi, Y. & Forrester, W. C. A DNA vector-based RNAi technology to suppress gene expression in mammalian cells. Proc. Natl Acad. Sci. USA 99, 5515-5520 (2002).
47. Wong, P. C. et al. An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar-degeneration of mitochondria. Neuron 14, 1105-1116 (1995).
48. Lariviere, R. C., Beaulieu, J. M., Nguyen, M. D. & Julien, J. P. Peripherin is not a contributing factor to motor neuron disease in a mouse model of amyotrophic lateral sclerosis caused by mutant superoxide dismutase. Neurobiol. Dis. 13, 158-166 (2003).